Hutch News
Results per Page:
‘Community coming together’: Obliteride raises more than $2.5M for cancer research
Record number of participants register to ride, walk and run for science at Fred Hutch
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Dr. Geoffrey Hill 3rd recipient of José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
Seattle mayor eager to realize the future of health care right here
Jenny Durkan addresses local life sciences representatives at Hutch roundtable
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
5 researchers receive awards to explore immunotherapy single-cell RNA sequencing
Projects accelerate Hutch position as early adopter of scRNA-seq technology
B56-PP2A takes the cycle out of cyclin E
From the Clurman Lab (Human Biology and Clinical Research Divisions)
Physician-scientist Dr. Bruce Clurman named executive vice president and deputy director of Fred Hutch
Clurman will focus on team science, interdisciplinary collaboration in pursuit of new cures, said President and Director Dr. Gary Gilliland
Wellcome funds for translational research
Clurman, Yee receive 5-year Burroughs Wellcome Fund awards for novel cancer-treatment research
Fred Hutchinson Cancer Research Center Investigators Use Guilt-by-Association Strategy to Track Potential Cancer Causing Genes
Represents a key step toward the quest by cancer biologists to characterize the cellular pathways that distinguish one type of cancer from another